Search Results

Astellas Pharma Inc. announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA.

Myeloid Therapeutics, Inc., a clinical-stage mRNA-immunotherapy company, announced that it will collaborate with the New South Wales Government in Australia to create a world-class RNA manufacturing and research facility.

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to lower drug prices.

Tiba Biotech , a preclinical biopharmaceutical company, today announced it has entered into a five-year, multi-million US dollar agreement with the Australian state government of New South Wales (NSW) to develop next-generation mRNA vaccines against emergency animal diseases that threaten Australia’s livestock industry and domestic food security.

Parse Biosciences today announced an agreement with Bogotá, Colombia-based Gencell Pharma to extend Parse’s reach in Colombia specifically and also across South America.